Death | No | Yes | P-value |
---|---|---|---|
N | 806 | 524 | |
Age (years) | 56.1 ± 12.1 | 59.9 ± 11.2 | < 0.001 |
Tumor size (cm) | 4.3 ± 2.5 | 5.2 ± 2.6 | < 0.001 |
NLR | 2.3 ± 1.6 | 3.0 ± 3.4 | < 0.001 |
PLR | 145.0 ± 71.6 | 156.8 ± 93.5 | 0.033 |
Sex | 0.862 | ||
Female | 259 (32.1%) | 166 (31.7%) | |
Male | 547 (67.9%) | 358 (68.3%) | |
Tumor location | < 0.001 | ||
Upper third | 253 (31.4%) | 258 (49.2%) | |
Middle third | 173 (21.5%) | 105 (20.0%) | |
Lower third | 380 (47.1%) | 161 (30.7%) | |
Histological grade | 0.005 | ||
Well differentiated | 155 (19.2%) | 70 (13.4%) | |
Poorly differentiated | 651 (80.8%) | 454 (86.6%) | |
TNM stage | < 0.001 | ||
1 | 203 (25.2%) | 17 (3.2%) | |
2 | 267 (33.1%) | 67 (12.8%) | |
3 | 336 (41.7%) | 440 (84.0%) | |
COP.NLR | < 0.001 | ||
0 | 537 (66.6%) | 293 (55.9%) | |
1 | 222 (27.5%) | 192 (36.6%) | |
2 | 47 (5.8%) | 39 (7.4%) |